Pulmonary Sarcoidosis: Diagnosis and Treatment

Mayo Clinic Proceedings

Volumn 91, Issue 7, 2016, Pages 946-954

  Carmona, Eva M ^a   Kalra, Sanjay ^a   Ryu, Jay H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PREDNISONE;

ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; BERYLLIOSIS; CALCIUM METABOLISM; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERCALCEMIA; LEUKOPENIA; LUNG FUNCTION TEST; LUNG NODULE; LUNG SARCOIDOSIS; LYMPHOCYTOPENIA; PATHOGENESIS; PNEUMOTHORAX; PROTEIN BLOOD LEVEL; REVIEW; THORAX RADIOGRAPHY; ADULT; AGE DISTRIBUTION; DIAGNOSTIC IMAGING; INCIDENCE; INCIDENTAL FINDING; LYMPHADENOPATHY; MIDDLE AGED; PATHOPHYSIOLOGY; SARCOIDOSIS, PULMONARY; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; LYMPHADENOPATHY; MIDDLE AGED; RADIOGRAPHY, THORACIC; SARCOIDOSIS, PULMONARY; YOUNG ADULT;

EID: 84991725988     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2016.03.004     Document Type: Review

References (37)

1. 1 Newman, L.S., Rose, C.S., Bresnitz, E.A., et al., ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170:12 (2004), 1324–1330.
2. 2 ACCESS Research Group. Design of a case control etiologic study of sarcoidosis (ACCESS). J Clin Epidemiol 52:12 (1999), 1173–1186.
3. 3 Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:2 (1999), 736–755.
4. 4 Chen, E.S., Song, Z., Willett, M.H., et al. Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 181:4 (2010), 360–373.
5. 5 Dubaniewicz, A., Microbial and human heat shock proteins as ‘danger signals’ in sarcoidosis. Hum Immunol 74:12 (2013), 1550–1558.
6. 6 Berlin, M., Fogdell-Hahn, A., Olerup, O., Eklund, A., Grunewald, J., HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 156:5 (1997), 1601–1605.
7. 7 Fischer, A., Rybicki, B.A., Granuloma genes in sarcoidosis: what is new?. Curr Opin Pulm Med 21:5 (2015), 510–516.
8. 8 Grunewald, J., Kaiser, Y., Ostadkarampour, M., et al. T-cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis. Eur Respir J 47:3 (2016), 898–909.
9. 9 Wahlström, J., Dengjel, J., Persson, B., et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 117:11 (2007), 3576–3582.
10. 10 Clayton, G.M., Wang, Y., Crawford, F., et al. Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Cell 158:1 (2014), 132–142.
11. 11 Dempsey, O.J., Paterson, E.W., Kerr, K.M., Denison, A.R., Sarcoidosis. BMJ, 339, 2009, b3206.
12. 12 Baughman, R.P., Teirstein, A.S., Judson, M.A., et al., Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:10, pt 1 (2001), 1885–1889.
13. 13 Birnie, D.H., Sauer, W.H., Bogun, F., et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:7 (2014), 1305–1323.
14. 14 Ungprasert, P., Carmona, E.M., Crowson, C.S., Matteson, E.L., Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study. Lung 194:1 (2016), 91–95.
15. 15 Furuya, K., Yamaguchi, E., Itoh, A., et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 51:8 (1996), 777–780.
16. 16 Baughman, R.P., Engel, P.J., Taylor, L., Lower, E.E., Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 138:5 (2010), 1078–1085.
17. 17 Scadding, J.G., Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. Br Med J 2:5261 (1961), 1165–1172.
18. 18 Hillerdal, G., Nöu, E., Osterman, K., Schmekel, B., Sarcoidosis: epidemiology and prognosis; a 15-year European study. Am Rev Respir Dis 130:1 (1984), 29–32.
19. 19 Spagnolo, P., Sverzellati, N., Wells, A.U., Hansell, D.M., Imaging aspects of the diagnosis of sarcoidosis. Eur Radiol 24:4 (2014), 807–816.
20. 20 Wong, M., Yasufuku, K., Nakajima, T., et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 29:6 (2007), 1182–1186.
21. 21 Culver, D.A., Costabel, U., EBUS-TBNA for the diagnosis of sarcoidosis: is it the only game in town?. [editorial] J Bronchology Interv Pulmonol 20:3 (2013), 195–197.
22. 22 Agarwal, R., Srinivasan, A., Aggarwal, A.N., Gupta, D., Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 106:6 (2012), 883–892.
23. 23 Trisolini, R., Lazzari Agli, L., Tinelli, C., De Silvestri, A., Scotti, V., Patelli, M., Endobronchial ultrasound- guided transbronchial needle aspiration for diagnosis of sarcoidosis in clinically unselected study populations. Respirology 20:2 (2015), 226–234.
24. 24 Plit, M.L., Havryk, A.P., Hodgson, A., et al. Rapid cytological analysis of endobronchial ultrasound-guided aspirates in sarcoidosis. Eur Respir J 42:5 (2013), 1302–1308.
25. 25 Nagai, S., Izumi, T., Bronchoalveolar lavage: still useful in diagnosing sarcoidosis?. Clin Chest Med 18:4 (1997), 787–797.
26. 26 Mukhopadhyay, S., Wilcox, B.E., Myers, J.L., et al. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest 144:3 (2013), 813–824.
27. 27 Reich, J.M., Brouns, M.C., O'Connor, E.A., Edwards, M.J., Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest 113:1 (1998), 147–153.
28. 28 Judson, M.A., Baughman, R.P., Costabel, U., Mack, M., Barnathan, E.S., The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial. Respir Med 108:1 (2014), 189–194.
29. 29 Gibson, G.J., Prescott, R.J., Muers, M.F., et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 51:3 (1996), 238–247.
30. 30 Gottlieb, J.E., Israel, H.L., Steiner, R.M., Triolo, J., Patrick, H., Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy. Chest 111:3 (1997), 623–631.
31. 31 Pietinalho, A., Tukiainen, P., Haahtela, T., Persson, T., Selroos, O., Finnish Pulmonary Sarcoidosis Study Group. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest 121:1 (2002), 24–31.
32. 32 Judson, M.A., Boan, A.D., Lackland, D.T., The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 29:2 (2012), 119–127.
33. 33 Judson, M.A., An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest 115:4 (1999), 1158–1165.
34. 34 Axelrod, L., Glucocorticoid therapy. Medicine (Baltimore) 55:1 (1976), 39–65.
35. 35 Schutt, A.C., Bullington, W.M., Judson, M.A., Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med 104:5 (2010), 717–723.
36. 36 Yale, S.H., Limper, A.H., Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:1 (1996), 5–13.
37. 37 Limper, A.H., Knox, K.S., Sarosi, G.A., et al., American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 183:1 (2011), 96–128.